Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
SY1-H5225 | Human | Human Syndecan-1 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
SY1-H5253 | Human | Human Syndecan-1 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
SD1-HF228 | Human | FITC-Labeled Human Syndecan-1 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
SY1-H82F3 | Human | Biotinylated Human Syndecan-1 Protein, Fc,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
SY1-H82E2 | Human | Biotinylated Human Syndecan-1 Protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
SD1-H5228 | Human | Human Syndecan-1 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
ATLCAR.CD138 (UNC Lineberger Comprehensive Cancer Center) | Phase Ⅰ | UNC Lineberger Comprehensive Cancer Center | Multiple myeloma (MM), Immunological disorders | Details | |
CART-138 (Chinese PLA General Hospital) | Phase Ⅱ | General Hospital of the People's Liberation Army | Multiple myeloma (MM) | Details | |
Indatuximab ravtansine | BT-062; nBT-062 | Phase Ⅱ | Biotest | Breast cancer, Multiple myeloma (MM), Bladder cancer | Details |
This web search service is supported by Google Inc.